MRF-Logo2019-Horizontal-RGB
FDA Approves New Targeted Therapy Combination (Vemurafenib and Cobimetinib) to Treat Advanced Melanoma
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

FDA Approves New Targeted Therapy Combination (Vemurafenib and Cobimetinib) to Treat Advanced Melanoma

› Forums › General Melanoma Community › FDA Approves New Targeted Therapy Combination (Vemurafenib and Cobimetinib) to Treat Advanced Melanoma

  • This topic is empty.
  • Post
    • November 10, 2015 at 6:18 pm
    lsmith – MRF
    Keymaster

      Hi all,

      The FDA just approved Cotellic (cobimetinib) to be used in combination with Zelboraf (vemurafenib) to treat advanced melanoma that has spread to other parts of the body or can’t be removed by surgery, and that has a certain type of abnormal gene (BRAF V600E or V600K mutation). Data showed that patients treated with the combination experienced a median of 12.25 months with no tumor progression, compared to 7.2 months for patients on vemurafenib alone. This approval means melanoma patients with this specific gene have another treatment option to fight their cancer!

      Read the MRF's statement here.

       

      – Lauren, MRF

    • You must be logged in to reply to this topic.
    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

    Popular Topics